nortran pharmaceuticals

Nortran Signs Licensing Agreement With Astrazeneca

Under the terms of the agreement, Nortran Pharmaceuticals Inc. will grant AstraZeneca PLC an exclusive worldwide license to develop and market a novel antiarrhythmic drug candidate in exchange for upfront, milestone, and royalty payments. AstraZeneca will pay for all development and marketing costs. The agreement covers a single Nortran antiarrhythmic drug candidate, allowing Nortran the Read more about Nortran Signs Licensing Agreement With Astrazeneca[…]